Congo, Democratic Republic of the vs Kenya: The number of people with susceptibility test result for rifampicin
Congo, Democratic Republic of the
28,577
in 2021
Kenya
24,832
in 2021
Congo, Democratic Republic of the rank
10th
Kenya rank
13th
The number of people with susceptibility test result for rifampicin over time
- Congo, Democratic Republic of the
- Kenya
How they compare
Congo, Democratic Republic of the currently reports 28,577 against 24,832 in Kenya, a difference of 3,745.
That makes Congo, Democratic Republic of the's figure about 1.2 times Kenya's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Kenya ahead.
Congo, Democratic Republic of the ranks 10th and Kenya ranks 13th of 155 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4,788 | 29,916 | 25,128 | Kenya |
| 2020s | 19,926 | 28,802 | 8,876 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo, Democratic Republic of the or Kenya?
- Congo, Democratic Republic of the, at 28,577 against 24,832 in Kenya as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo, Democratic Republic of the and Kenya?
- 3,745, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Kenya?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo, Democratic Republic of the and Kenya rank globally for the number of people with susceptibility test result for rifampicin?
- Congo, Democratic Republic of the ranks 10th and Kenya ranks 13th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.